Light-activatable liposomes for repetitive on-demand drug release and immunopotentiation in hypoxic tumor therapy

作者：Yang, Yuanyuan; Liu, Xin; Ma, Wen; Xu, Qing; Chen, Gui; Wang, Yufei; Xiao, Haihua; Li, Nan; Liang, Xing-Jie^*; Yu, Meng^*; Yu, Zhiqiang^*

来源：Biomaterials, 2021, 265: 120456.

DOI：10.1016/j.biomaterials.2020.120456

• Light-activatable liposomes
• Repetitive drug release
• Oxidative equilibrium
• Hypoxia alleviation
• Immunopotentiation

External stimuli-responsive nanomedicine with desirable repetitive on-demand drug release character is postulated to greatly accommodate patients' flexible medication regime. To this object, light-activatable liposomes (Pt/Ce6-LP) integrated with both a Ce6 photodynamic component and a tetravalent platinum prodrug (Pt(IV)) chemotherapeutic component are engineered. This multifunctional system was rationally designed using unsaturated phospholipid to achieve repetitive on-demand drug release under discontinuous light irradiation, thus performing chemo-photodynamic therapy effect and immunopotentiation in hypoxic tumor. Furthermore, glutathione (GSH) consumption during transformation from Pt(IV) prodrug to Pt(II) can avoid depletion of reactive oxygen species (ROS) in photodynamic therapy (PDT). Note this positive feedback loop appears to remodel the redox balance of H2O2 and GSH in tumors, alleviating the hypoxic tumor microenvironment. The alleviated hypoxia is found to be critical to the enhancement of PDT efficacy, reversal of cisplatin resistance in tumors, and polarization of tumor-associated macrophages (TAMs) to the immunocompetent M1-phynotype. Pt/Ce6-LP with light radiation demonstrates significant antitumor effect and persistent post-medication inhibition in patient-derived tumor xenograft model of hepatocellular carcinoma.

• 单位
  1; 南方医科大学; 国家纳米科学中心; 中国科学院; 中国科学院研究生院; 天津大学